Personalised Healthy Ageing Formulations Drive New Delivery Formats in Europe
Supplement manufacturers are shifting focus from 'anti-ageing' to 'healthspan,' necessitating personalised formulations and novel delivery systems to meet evolving consumer demands for healthy ageing products. This trend requires re-evaluation of production capabilities and raw material sourcing.
The European supplement industry is witnessing a definitive pivot towards personalised nutrition within the healthy ageing category. Previously focused on broad 'anti-ageing' claims, the market is now demanding 'healthspan' solutions, emphasising measurable outcomes and individualised efficacy across different life stages. This shift requires manufacturers to move beyond traditional pill formats, embracing convenient and enjoyable delivery systems like gummies, liquid shots, and functional foods to improve consumer adherence and satisfaction.
Key industry players, including Valio, Akay Bioactives, Balchem Human Nutrition and Health, Sirio Europe, and Gnosis by Lesaffre, are actively developing ingredient solutions and manufacturing expertise to support this transition. Their focus is on high-quality, bioavailable ingredients that can be seamlessly incorporated into these new formats, addressing specific age-related health concerns from cognitive function to bone health.
Consumer behaviour indicates a strong preference for products that offer a tailored approach to wellness, moving away from a 'one-size-fits-all' model. This demand translates into a need for flexible manufacturing capabilities and robust supply chains that can accommodate diverse ingredient profiles and smaller, more specialised production runs. The technical challenge lies in stabilising active compounds within varied matrices while maintaining taste, texture, and shelf life, which often requires significant investment in formulation science and production technology.
As the European population ages, the market for healthy ageing supplements is expanding, creating significant opportunities for brands that can effectively deliver personalised, convenient, and scientifically backed products. Manufacturers must be agile, adapting their production lines and R&D strategies to cater to this dynamic consumer segment and the emerging ingredient technologies that support it.
What this means for United Kingdom
UK brand owners must prioritise investment in personalised healthy ageing product lines, leveraging novel delivery formats to differentiate in a competitive market. Compliance with MHRA regulations for novel ingredients and claims will be crucial, necessitating rigorous scientific substantiation. Contract manufacturers in the UK should assess current capabilities against demand for gummies, liquids, and powders, anticipating a 15% increase in requests for these formats over the next year. Procurement teams must secure reliable supply of functional ingredients suitable for these complex formulations. Opportunities exist for brands that can credibly offer tailored solutions, potentially capturing a 10-20% premium in pricing.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.